Fintel reports that on December 5, 2024, Mizuho downgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from ...
Mizuho analyst Vikram Malhotra downgraded Sabra Health Care (SBRA) to Neutral from Outperform with an unchanged price target ...